查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1741106

威爾姆氏腫瘤蛋白市場按產品類型、應用、最終用戶、檢測方法、疾病階段和地區分類

Wilms Tumor Protein Market, By Product Type, By Application, By End User, By Detection Method, By Disease Stage, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 160 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2025 年威爾姆氏腫瘤蛋白市場規模估計為 31.9 億美元，預計到 2032 年將達到 43.7 億美元，2025 年至 2032 年的年複合成長率為 4.6%。

報告範圍 報告詳細資訊
基準年 2024 2025年的市場規模 31.9億美元
效能數據 從2020年到2024年 預測期 2025年至2032年
預測期：2025-2032年年複合成長率： 4.60% 2032年價值預測 43.7億美元

威爾姆氏腫瘤蛋白是一種轉錄因子，在多種癌症的進展中發揮重要作用。它也被證明與化療抗藥性有關。因此，威爾姆氏腫瘤蛋白被認為是開發新型抗癌藥物的有希望的標靶。根據NCBI報導，威爾姆氏腫瘤腫瘤蛋白參與染色質重塑複合物，並促進多種基因的表達。它已被證明與多種化療藥物相互作用，包括道諾黴素和Mitoxantron。

市場動態：

預計預測期內，全球癌症患者數量的增加將推動全球威爾姆氏腫瘤蛋白市場的成長。此外，人們對威爾姆氏腫瘤及其治療和診斷的認知不斷提高，也有望推動預測期內全球威爾姆氏腫瘤蛋白市場的成長。根據美國癌症協會 2020 年 1 月發布的數據， 威爾姆氏腫瘤是兒童最常見的腎癌類型。美國每年報告 500-600 例威爾姆氏腫瘤新病例，這一數字保持相對穩定。 Wilms威爾姆氏腫瘤約佔所有兒童癌症的 5%。

然而，預計診斷和治療程序的高成本將在預測期內阻礙全球威爾姆氏腫瘤威爾姆氏腫瘤市場的成長。診斷和治療程序的高成本可能會顯著阻礙全球威爾姆斯腫瘤蛋白市場的成長。昂貴的診斷測試和治療可能會限制患者獲得治療，尤其是在醫療資源有限的地區。此類成本障礙可能會降低患者對威爾姆氏腫瘤蛋白相關治療方法和診斷的接受度，從而可能影響市場擴張，並阻礙其覆蓋更廣泛患者群體的能力。

本研究的主要特點

  • 本報告對全球威爾姆氏腫瘤蛋白市場進行了詳細分析，並以 2024 年為基準年，展示了預測期（2025-2032 年）的市場規模和年複合成長率（CAGR%）。
  • 它還揭示了各個領域的潛在商機，並解釋了該市場的有吸引力的投資提案矩陣。
  • 它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。
  • 它根據公司亮點、產品系列、關鍵亮點、財務績效和策略等參數，介紹了全球威爾姆氏腫瘤蛋白市場的主要企業概況。
  • 本報告的見解將使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
  • 全球威爾姆氏腫瘤蛋白市場報告針對該行業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
  • 相關人員將透過用於分析全球威爾姆氏腫瘤蛋白市場的各種策略矩陣更輕鬆地做出決策。

目錄

第1章 調查目的與前提條件

  • 研究目標
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告描述
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map（COM）

第3章市場動態、法規與趨勢分析

  • 市場動態
    • 驅動程式
  • 針對威爾姆氏腫瘤的標靶治療需求不斷成長
  • 癌症診斷和治療領域的技術發展
    • 限制因素
  • 診斷和治療費用高昂
    • 機會
  • 增加對威爾姆氏腫瘤研究的資助
  • 影響分析
  • 主要亮點
  • 監管情景
  • 產品發布/核准
  • PEST分析
  • 波特分析
  • 併購場景

4. 全球威爾姆氏腫瘤蛋白市場-冠狀病毒（COVID-19）大流行的影響

  • COVID-19流行病學
  • 供需側分析
  • 經濟影響

5. 2020 年至 2032 年全球威爾姆氏腫瘤蛋白市場（依產品類型）

  • 抗體
  • 檢測試劑套件
  • 重組蛋白
  • 其他

6. 2020 年至 2032 年全球威爾姆氏腫瘤蛋白市場（依應用）

  • 癌症診斷
  • 癌症治療
  • 研究與開發
  • 其他

7. 2020 年至 2032 年全球威爾姆氏腫瘤蛋白市場（依最終用戶分類）

  • 醫院
  • 診斷實驗室
  • 研究所
  • 其他

8. 2020 年至 2032 年全球威爾姆氏腫瘤蛋白市場（依檢測方法）

  • 免疫組織化學（IHC）
  • 酵素免疫分析法（ELISA）
  • 西方印漬術
  • 聚合酵素鏈鎖反應（PCR）
  • 其他

9. 2020 年至 2032 年按疾病階段分類的全球威爾姆氏腫瘤蛋白市場

  • 診斷
  • 監測和預測

10. 2020 年至 2032 年全球威爾姆氏腫瘤蛋白市場（按地區）

  • 北美洲
      • 美國
      • 加拿大
  • 歐洲
      • 英國
      • 德國
      • 義大利
      • 法國
      • 西班牙
      • 俄羅斯
      • 其他歐洲國家
  • 亞太地區
      • 中國
      • 印度
      • 日本
      • ASEAN
      • 澳洲
      • 韓國
      • 其他亞太地區
  • 拉丁美洲
      • 巴西
      • 墨西哥
      • 阿根廷
      • 其他拉丁美洲
  • 中東
      • GCC
      • 以色列
      • 其他中東地區
  • 非洲
      • 北非
      • 中部非洲
      • 南非

第11章競爭格局

  • Abcam plc.
  • Thermo Fisher Scientific, Inc.
  • Santa Cruz Biotechnology, Inc.
  • Novus Biologicals, LLC
  • R&D Systems, Inc.（a subsidiary of Bio-Techne Corporation）
  • OriGene Technologies, Inc.
  • Cell Signaling Technology, Inc.
  • Merck KGaA
  • BioLegend, Inc.
  • Genetex, Inc.（a subsidiary of Novus Biologicals, LLC）
  • Agilent Technologies, Inc.
  • Proteintech Group, Inc.
  • Sino Biological Inc.
  • Boster Biological Technology
  • Fitzgerald Industries International

第12章 章節

  • 調查方法
  • 關於出版商
簡介目錄
Product Code: CMI5825

Wilms Tumor Protein Market is estimated to be valued at USD 3.19 Bn in 2025 and is expected to reach USD 4.37 Bn by 2032, growing at a compound annual growth rate (CAGR) of 4.6% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 3.19 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 4.60% 2032 Value Projection: USD 4.37 Bn

Wilms tumor protein is a transcription factor that plays an important role in the progression of various types of cancer. It has also been shown to be associated with resistance to chemotherapies. As a result, Wilms tumor protein has been proposed to be a promising target for the development of new anti-cancer drugs. According to NCBI, Wilms tumor protein is involved in the chromatin remodeling complex and promotes the expression of several genes. It has been shown to interact with several chemotherapeutic agents including daunorubicin and mitoxantrone.

Market Dynamics:

Increasing cancer cases worldwide is expected to drive growth of the global wilms tumor protein market over the forecast period. Moreover, increasing awareness regarding Wilms tumor and its treatment and diagnosis is also expected to propel growth of the global Wilms tumor protein market over the forecast period. According to the data published by American Cancer Society in January 2020, Wilms tumor stands as the predominant form of kidney cancer found in children. Annually, in the U.S., 500 to 600 new Wilms tumor cases are reported, a figure that has exhibited relatively consistent levels over an extended period. Wilms tumors account for approximately 5% of all childhood cancer cases.

However, high cost of diagnosis and treatment procedures is expected to hinder growth of the global Wilms tumor protein market over the forecast period. The high cost of diagnosis and treatment procedures can significantly hinder the growth of the global Wilms tumor protein market. Expensive diagnostic tests and treatments may limit accessibility for patients, particularly in regions with limited healthcare resources. This cost barrier could reduce patient uptake of Wilms tumor protein-related therapies and diagnostics, potentially impacting the market's expansion and inhibiting the ability to reach a broader patient population.

Key features of the study:

  • This report provides in-depth analysis of the global wilms tumor protein market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global wilms tumor protein market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Abcam plc, Thermo Fisher Scientific, Inc., Santa Cruz Biotechnology, Inc., Novus Biologicals, LLC, R&D Systems, Inc. (a subsidiary of Bio-Techne Corporation), OriGene Technologies, Inc., Cell Signaling Technology, Inc., Merck KGaA, BioLegend, Inc., Genetex, Inc. (a subsidiary of Novus Biologicals, LLC), Agilent Technologies, Inc., Proteintech Group, Inc., Sino Biological Inc., Boster Biological Technology, and Fitzgerald Industries International
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global wilms tumor protein market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global wilms tumor protein market

Global Wilms Tumor Protein Market Detailed Segmentation:

  • By Product Type:
    • Antibodies
    • Assay Kits
    • Recombinant Proteins
    • Others
  • By Application:
    • Cancer Diagnosis
    • Cancer Treatment
    • Research and Development
    • Others
  • By End User:
    • Hospitals
    • Diagnostic Laboratories
    • Research Institutes
    • Others
  • By Detection Method:
    • Immunohistochemistry (IHC)
    • Enzyme-Linked Immunosorbent Assay (ELISA)
    • Western Blotting
    • Polymerase Chain Reaction (PCR)
    • Others
  • By Disease Stage:
    • Diagnosis
    • Monitoring and Prognosis
  • By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • Abcam plc
    • Thermo Fisher Scientific, Inc.
    • Santa Cruz Biotechnology, Inc.
    • Novus Biologicals, LLC
    • R&D Systems, Inc. (a subsidiary of Bio-Techne Corporation)
    • OriGene Technologies, Inc.
    • Cell Signaling Technology, Inc.
    • Merck KGaA
    • BioLegend, Inc.
    • Genetex, Inc. (a subsidiary of Novus Biologicals, LLC)
    • Agilent Technologies, Inc.
    • Proteintech Group, Inc.
    • Sino Biological Inc.
    • Boster Biological Technology
    • Fitzgerald Industries International

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Wilms Tumor Protein, By Product Type
    • Market Wilms Tumor Protein, By Application
    • Market Wilms Tumor Protein, By End User
    • Market Wilms Tumor Protein, By Detection Method
    • Market Wilms Tumor Protein, By Disease Stage
    • Market Wilms Tumor Protein, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
  • Increasing demand for targeted therapies for Wilms tumor treatment
  • Technological developments in the field of cancer diagnostics and treatment
    • Restraints
  • High cost of diagnosis and treatment procedures
    • Opportunities
  • Growing funding for research on Wilms tumor
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Wilms Tumor Protein Market- Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Wilms Tumor Protein Market, By Product Type, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Antibodies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Assay Kits
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Recombinant Proteins
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

6. Global Wilms Tumor Protein Market, By Application, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Cancer Diagnosis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Cancer Treatment
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Research and Development
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

7. Global Wilms Tumor Protein Market, By End User, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Diagnostic Laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Research Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

8. Global Wilms Tumor Protein Market, By Detection Method, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Immunohistochemistry (IHC)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,( US$ Bn)
  • Enzyme-Linked Immunosorbent Assay (ELISA)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Western Blotting
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Polymerase Chain Reaction (PCR)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

9. Global Wilms Tumor Protein Market, By Disease Stage, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Diagnosis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Monitoring and Prognosis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

10. Global Wilms Tumor Protein Market, By Region, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Region, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Region, 2025-2032
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Detection Method, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Stage, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
      • U.S.
      • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Detection Method, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Stage, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Detection Method, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Stage, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Detection Method, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Stage, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Detection Method, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Stage, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Detection Method, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Stage, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-Region, 2020-2032, (US$ Bn)
      • North Africa
      • Central Africa
      • South Africa

11. Competitive Landscape

  • Abcam plc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Thermo Fisher Scientific, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Santa Cruz Biotechnology, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Novus Biologicals, LLC
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • R&D Systems, Inc. (a subsidiary of Bio-Techne Corporation)
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • OriGene Technologies, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Cell Signaling Technology, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Merck KGaA
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • BioLegend, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Genetex, Inc. (a subsidiary of Novus Biologicals, LLC)
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Agilent Technologies, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Proteintech Group, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Sino Biological Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Boster Biological Technology
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Fitzgerald Industries International
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Analyst Views

12. Section

  • Research Methodology
  • About us